2023
DOI: 10.1111/cyt.13239
|View full text |Cite
|
Sign up to set email alerts
|

Cytological findings in a case of endocrine mucin‐producing sweat gland carcinoma with metastasis to salivary glands

Abstract: Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is a rare, low-grade skin adnexal neoplasm. It usually affects elderly patients, is more frequently observed in women, and has a predilection for the periorbital skin. It shares the same histological and immunohistochemical characteristics as solid papillary carcinoma (SPC) of the breast. 1 Local recurrences are common in EMPSGC, but metastases have not been reported until recently; 2-4 to date, only three cases have been reported, all of which involved … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 7 publications
0
7
0
Order By: Relevance
“…Endocrine mucin-producing sweat gland carcinoma was previously believed to be a low-grade neuroendocrine neoplasm with an indolent clinical course and a low rate of recurrence (<10%) following excision [2,3,5,12]. There have now been seven reported cases since 2020 of metastases, including this case, with the majority metastasizing to the parotid gland and none metastasizing to the lungs [3,7,8]. It is important to differentiate this lesion from mucinous carcinoma and breast solid papillary carcinoma with neuroendocrine differentiation (SPCND).…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Endocrine mucin-producing sweat gland carcinoma was previously believed to be a low-grade neuroendocrine neoplasm with an indolent clinical course and a low rate of recurrence (<10%) following excision [2,3,5,12]. There have now been seven reported cases since 2020 of metastases, including this case, with the majority metastasizing to the parotid gland and none metastasizing to the lungs [3,7,8]. It is important to differentiate this lesion from mucinous carcinoma and breast solid papillary carcinoma with neuroendocrine differentiation (SPCND).…”
Section: Discussionmentioning
confidence: 99%
“…It is important to differentiate this lesion from mucinous carcinoma and breast solid papillary carcinoma with neuroendocrine differentiation (SPCND). Mucinous carcinoma is differentiated due to its small clusters of cells with cribriform or tubular structures in large pools of extracellular mucin, whereas metastatic SPCND shows similar features and an immunohistochemical profile [2,3,13]. Although classically thought of as having more than 90% extracellular mucin, neuroendocrine and non-neuroendocrine mucinous carcinoma is now well known to exist in either pure form (>90%) or in a mixed pattern, which can lead to diagnostic confusion if the mucinous component is not properly sampled, as its presence, even in mixed form, should classify the lesion as a mucinous carcinoma [12,14,15].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations